All results
12 results for phase 2 randomized double blind placebo controlled evaluation safety and efficacy bms
-
JNT-517
The goal of Parts A and B of this Phase 1, first-in-human, randomized study is to assess the safety, tolerability, and pharmacokinetics (PK) of single (SAD)…
- Ages
- 18 Years - 65 Years
- Sexes
- All
-
RAISE
This study will evaluate the effectiveness and safety of an investigational product (IP), intravenous (IV) ganaxolone, to treat participants with status…
- Ages
- 12 Years - N/A
- Sexes
- All